Index
Grant: University of Michigan — COVID-19 Protein Production (Aubree Gordon) (Coefficient Giving → University of Michigan)
Verdictconfirmed95%
1 check · 4/9/2026Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Our claim
entire record- Grantee
- University of Michigan
- Name
- University of Michigan — COVID-19 Protein Production (Aubree Gordon)
- Amount
- $348,000
- Currency
- USD
- Date
- April 2020
- Notes
[Scientific Research] Grant Investigators: Chris Somerville and Heather Youngs This page was reviewed but not written by the grant investigators. University of Michigan staff also reviewed this page prior to publication. Open Philanthropy recommended a grant of $348,000 to th… expand
[Scientific Research] Grant Investigators: Chris Somerville and Heather Youngs This page was reviewed but not written by the grant investigators. University of Michigan staff also reviewed this page prior to publication. Open Philanthropy recommended a grant of $348,000 to the University of Michigan to support the production of antigenic proteins from the COVID-19 virus for use in serological tests, led by Professor Aubree Gordon. This funding is intended to support protein production, strain optimization, serological test validation, and the shipment of proteins to other laboratories in the United States and abroad for use in serological tests. The tests could expedite the selection of plasma from patients who have recovered from COVID-19 for use in treatments against the virus. This falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.
Source evidence
1 src · 1 checkconfirmed95%deterministic-row-match · 4/9/2026
- Name
- University of Michigan — COVID-19 Protein Production (Aubree Gordon)
- Grantee
- University of Michigan
- Focus Area
- Scientific Research
- Amount
- $348,000.00
- Date
- April 2020
NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Case № WBSftCwsh3Filed 4/9/2026Confidence 95%